In Vivo Cardiac Cellular Reprogramming Efficacy is Enhanced by Angiogenic Preconditioning of the Infarcted Myocardium with Vascular Endothelial Growth Factor

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2013 Jan 15

PMID 23316332

Citations 73

Authors

Megumi Mathison

Robert P Gersch

Ahmed Nasser

Sarit Lilo

Mallory Korman

Mitchell Fourman

Neil Hackett

Kenneth Shroyer

Jianchang Yang

Yupo Ma

Ronald G Crystal

Todd K Rosengart

Affiliations

Soon will be listed here.

Abstract

Background: In situ cellular reprogramming offers the possibility of regenerating functional cardiomyocytes directly from scar fibroblasts, obviating the challenges of cell implantation. We hypothesized that pretreating scar with gene transfer of the angiogenic vascular endothelial growth factor (VEGF) would enhance the efficacy of this strategy.

Methods And Results: Gata4, Mef2c, and Tbx5 (GMT) administration via lentiviral transduction was demonstrated to transdifferentiate rat fibroblasts into (induced) cardiomyocytes in vitro by cardiomyocyte marker studies. Fisher 344 rats underwent coronary ligation and intramyocardial administration of an adenovirus encoding all 3 major isoforms of VEGF (AdVEGF-All6A(+)) or an AdNull control vector (n=12/group). Lentivirus encoding GMT or a GFP control was administered to each animal 3 weeks later, followed by histologic and echocardiographic analyses. GMT administration reduced the extent of fibrosis by half compared with GFP controls (12 ± 2% vs 24 ± 3%, P<0.01) and reduced the number of myofibroblasts detected in the infarct zone by 4-fold. GMT-treated animals also demonstrated greater density of cardiomyocyte-specific marker beta myosin heavy chain 7(+) cells compared with animals receiving GFP with or without VEGF (P<0.01). Ejection fraction was significantly improved after GMT vs GFP administration (12 ± 3% vs -7 ± 3%, P<0.01). Eight (73%) GFP animals but no GMT animals demonstrated decreased ejection fraction during this interval (P<0.01). Also, improvement in ejection fraction was 4-fold greater in GMT/VEGF vs GMT/null animals (17 ± 2% vs 4 ± 1%, P<0.05).

Conclusions: VEGF administration to infarcted myocardium enhances the efficacy of GMT-mediated cellular reprogramming in improving myocardial function and reducing the extent of myocardial fibrosis compared with the use of GMT or VEGF alone.

Citing Articles

Direct fibroblast reprogramming: an emerging strategy for treating organic fibrosis.

Lin H, Wang X, Chung M, Cai S, Pan Y J Transl Med. 2025; 23(1):240.

PMID: 40016790 PMC: 11869441. DOI: 10.1186/s12967-024-06060-3.

Emerging Insights into Sall4's Role in Cardiac Regenerative Medicine.

Yang J Cells. 2025; 14(3).

PMID: 39936946 PMC: 11817359. DOI: 10.3390/cells14030154.

Partial Cell Fate Transitions to Promote Cardiac Regeneration.

Yang J Cells. 2024; 13(23).

PMID: 39682750 PMC: 11640292. DOI: 10.3390/cells13232002.

Activation of a GPCR, ORL1 Receptor: A Novel Therapy to Prevent Heart Failure Progression.

Pathan S, Pugazenthi A, Dixon B, Wensel T, Rosengart T, Mathison M J Cardiovasc Dev Dis. 2024; 11(11).

PMID: 39590198 PMC: 11595155. DOI: 10.3390/jcdd11110355.

Recent advances and future prospects in direct cardiac reprogramming.

Xie Y, Van Handel B, Qian L, Ardehali R Nat Cardiovasc Res. 2024; 2(12):1148-1158.

PMID: 39196156 DOI: 10.1038/s44161-023-00377-w.

References

Srivastava D, Ieda M . Critical factors for cardiac reprogramming. Circ Res. 2012; 111(1):5-8. PMC: 3404813. DOI: 10.1161/CIRCRESAHA.112.271452. View

Lietz K, Long J, Kfoury A, Slaughter M, Silver M, Milano C . Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007; 116(5):497-505. DOI: 10.1161/CIRCULATIONAHA.107.691972. View

Taylor D, Atkins B, Hungspreugs P, Jones T, Reedy M, Hutcheson K . Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 1998; 4(8):929-33. DOI: 10.1038/nm0898-929. View

Leor J, Patterson M, Quinones M, Kedes L, Kloner R . Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium?. Circulation. 1996; 94(9 Suppl):II332-6. View

Reinecke H, Zhang M, Bartosek T, Murry C . Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation. 1999; 100(2):193-202. DOI: 10.1161/01.cir.100.2.193. View

Chen J, Krane M, Deutsch M, Wang L, Rav-Acha M, Gregoire S . Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circ Res. 2012; 111(1):50-5. PMC: 3390172. DOI: 10.1161/CIRCRESAHA.112.270264. View

Inagawa K, Miyamoto K, Yamakawa H, Muraoka N, Sadahiro T, Umei T . Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5. Circ Res. 2012; 111(9):1147-56. DOI: 10.1161/CIRCRESAHA.112.271148. View

Yu J, Vodyanik M, Smuga-Otto K, Antosiewicz-Bourget J, Frane J, Tian S . Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318(5858):1917-20. DOI: 10.1126/science.1151526. View

Okita K, Ichisaka T, Yamanaka S . Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448(7151):313-7. DOI: 10.1038/nature05934. View

10.

Song Y, Gehmert S, Sadat S, Pinkernell K, Bai X, Matthias N . VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes. Biochem Biophys Res Commun. 2007; 354(4):999-1003. DOI: 10.1016/j.bbrc.2007.01.095. View

11.

Passier R, Mummery C . Getting to the heart of the matter: direct reprogramming to cardiomyocytes. Cell Stem Cell. 2010; 7(2):139-41. DOI: 10.1016/j.stem.2010.07.004. View

12.

Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Matsuoka S . Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation. 2008; 118(5):498-506. DOI: 10.1161/CIRCULATIONAHA.108.769562. View

13.

Claes F, Vandevelde W, Moons L, Tjwa M . Another angiogenesis-independent role for VEGF: SDF1-dependent cardiac repair via cardiac stem cells. Cardiovasc Res. 2011; 91(3):369-70. DOI: 10.1093/cvr/cvr184. View

14.

Chen Y, Amende I, Hampton T, Yang Y, Ke Q, Min J . Vascular endothelial growth factor promotes cardiomyocyte differentiation of embryonic stem cells. Am J Physiol Heart Circ Physiol. 2006; 291(4):H1653-8. DOI: 10.1152/ajpheart.00363.2005. View

15.

Protze S, Khattak S, Poulet C, Lindemann D, Tanaka E, Ravens U . A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J Mol Cell Cardiol. 2012; 53(3):323-32. DOI: 10.1016/j.yjmcc.2012.04.010. View

16.

Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson S, Li B . Bone marrow cells regenerate infarcted myocardium. Nature. 2001; 410(6829):701-5. DOI: 10.1038/35070587. View

17.

Taylor D, Edwards L, Boucek M, Trulock E, Keck B, Hertz M . The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report--2004. J Heart Lung Transplant. 2004; 23(7):796-803. DOI: 10.1016/j.healun.2004.05.004. View

18.

Jayawardena T, Egemnazarov B, Finch E, Zhang L, Payne J, Pandya K . MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res. 2012; 110(11):1465-73. PMC: 3380624. DOI: 10.1161/CIRCRESAHA.112.269035. View

19.

Daskalopoulos E, Janssen B, Blankesteijn W . Myofibroblasts in the infarct area: concepts and challenges. Microsc Microanal. 2012; 18(1):35-49. DOI: 10.1017/S143192761101227X. View

20.

Min J, Yang Y, Converso K, Liu L, Huang Q, Morgan J . Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol (1985). 2001; 92(1):288-96. DOI: 10.1152/jappl.2002.92.1.288. View